Get Premium to unlock powerful stock data
HTG Molecular Diagnostics Inc logo

HTG Molecular Diagnostics Inc

$ 0.57 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
0.45
Market Cap:
$ 4.87M
Enterprise V:
$ -7.03M
Volume:
1.58M
Avg Vol (2M):
981.94K
Also Trade In:
Volume:
1.58M
Market Cap $:
4.87M
PE Ratio:
At Loss
Avg Vol (2-Month):
981.94K
Enterprise Value $:
-7.03M
PB Ratio:
0.45
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

HTG Molecular Diagnostics Inc
NAICS : 334510 SIC : 3826
3430 E. Global Loop, Tucson, AZ, USA, 85706
Description
HTG Molecular Diagnostics Inc is a commercial stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological sample, in liquid or solid forms. Its products include instruments, consumables and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.
Name Current Vs Industry Vs History
Cash-To-Debt 2.28
Equity-to-Asset 0.4
Debt-to-Equity 0.84
Debt-to-EBITDA -0.56
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -11.43
Distress
Grey
Safe
Beneish M-Score 71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.76
9-Day RSI 29.05
14-Day RSI 28.43
6-1 Month Momentum % -75.67
12-1 Month Momentum % -74.58

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.99
Quick Ratio 2.75
Cash Ratio 2.54
Days Inventory 180.04
Days Sales Outstanding 62.57
Days Payable 125.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -58.5

Financials (Next Earnings Date:2022-08-12 Est.)

HTGM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:HTGM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.655
EPS (TTM) ($) -2.49
Beta 1.6
Volatility % 109.21
14-Day RSI 28.43
14-Day ATR ($) 0.104356
20-Day SMA ($) 0.69384
12-1 Month Momentum % -74.58
52-Week Range ($) 0.5152 - 6.98
Shares Outstanding (Mil) 8.59

Piotroski F-Score Details

Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HTG Molecular Diagnostics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More